ProBiotix Health Plc (AQU:PBX)

Market Cap	13.05M
Revenue (ttm)	1.88M
Net Income (ttm)	-847.00K
Shares Out	158.17M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	8.50
Day's Range	n/a
52-Week Range	2.50 - 12.50
Beta	0.11
RSI	65.19
Earnings Date	May 30, 2025

About ProBiotix Health

ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. It offers YourBiotixMH for menopause health; YourBiotixPMH for post-menopause health; YourBiotixCH for cholesterol maintenance; YourBiotixCH InstaMelt for cholesterol health; YourBiotixBP for blood pressure reduction; and YourBiotixVH for vascular health support. The company was formerly known as ProBiotix Health Limited and changed its name to ProBiotix Health Plc in February 20...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2012
• Employees: 7
• Stock Exchange: Aquis Exchange
• Ticker Symbol: PBX

Financial Performance

In 2024, ProBiotix Health's revenue was 1.88 million, an increase of 12.55% compared to the previous year's 1.67 million. Losses were -847,000, 13.4% more than in 2023.